Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov chaw muag khoom ntawm cas 2213408-17-2 hynic-psma hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau kev lag luam wholesale bulk zoo cas 2213408-17-2 hynic-psma los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.
| CAS Nr: 2213408-17-2 | HYNIC-PSMA |
| Kev piav qhia | HYNIC-PSMA yog 99mTc daim ntawv teev cov duab ua ntej tsom rau prostate-specific membrane antigen (PSMA). urea-bond peptide ntu khi nrog qhov tshwj xeeb rau PSMA ntawm cov qog cell, thiab HYNIC chelator tuaj yeem ruaj khov chelate radionuclides xws li 99mTc nyob rau hauv cov mob me. Siv nyob rau hauv prostate cancer staging, metastasis imaging thiab PSMA txoj kev mechanism kev tshawb fawb. |
| Peptide purity (HPLC, %) | 95%/98%/99% |
| Theoretical molecular hnyav | ~ 1.1 kDa (xws li chelate thiab txuas) |
| Hloov kho hom | Qhov chaw tshwj xeeb N-terminal HYNIC chelator conjugation |
Khoom Description
| Khoom Lub Npe Lus Askiv | Product Abbreviation / Alias | Function Tags (comma-sib cais) | Core Structure | Molecular Formula | Exact Mass (Da) | Nruab nrab MW (Da) | Hloov kho Terminal | Qauv Length |
| HYNIC-PSMA | HYNIC-conjugated PSMA peptide; PSMA SPECT imaging precursor; CAS Nr .: 2213408-17-2 | PSMA targeting, 99mTc labeling, SPECT imaging, Prostate cancer tshawb fawb, HYNIC chelating peptide, Radionuclide theranostics | Glu-urea-Lys PSMA khi scaffold + hloov tau yooj yim txuas + HYNIC chelator | Loj hloov peptide, tsis muaj meej me me -molecule mis; raws li qhov tseeb batch MS | - | ~ 1100 (theoretical) | N-terminal HYNIC chelator thaiv | ~ 10 chav tsev (peptide + chelator) |
Physicochemical Solubility & Cia Parameters
| Khoom Code | Qhov tshwm sim | Ntev - Lub Sij Hawm Cia Cov Cai | Luv -Lub Sijhawm Cia Cov Cai | Kua Stability | Khoom hmoov ruaj khov |
| PEB-HPS001 | hmoov dawb | Khaws ntawm -20 degree, kaw, qhuav & tiv thaiv los ntawm lub teeb, aliquoted. ** nruj me ntsis txwv tsis pub hnyav hlau ions ** | Khoom hmoov ruaj khov rau 2 xyoos ntawm 2-8℃kaw thiab qhuav; npaj cov tshuaj tshiab ua ntej sau npe | ruaj khov rau 72 h ntawm 4℃nyob rau hauv hlau -dawb tej yam kev mob; ruaj khov rau 1 lub hlis ntawm -20℃hauv aliquots. ** Zoo solubility dej, dawb do soluble nyob rau hauv dej thiab labeling tsis **. HYNIC chelation qhov chaw yooj yim nyob los ntawm cov kab hnyav hlau; siv cov thawv tsis muaj hlau thiab cov tshuaj reagents. Urea daim ntawv cog lus ruaj khov rau acid / puag | ruaj khov rau 3 xyoos ntawm -20℃nyob rau hauv qhuav & tsaus ntuj |
Functional Description
| Khoom Code | Frontend Short Summary (rau cov npe tshawb nrhiav) | Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg | Cov cheeb tsam tshawb fawb (comma- cais) | Lub Hom Phiaj / Txoj Kev |
| PEB-HPS001 | HYNIC-chelated PSMA targeting peptide labelable with 99mTc for prostate cancer SPECT imaging | HYNIC-PSMA yog PSMA lub hom phiaj peptide optimized rau technetium-labeled SPECT imaging. Lub hauv paus binding domain txais ib Glu- urea-Lys tsis yog -peptide daim ntawv cog lus scaffold, uas khi nrog siab tshwj xeeb thiab affinity rau PSMA protein ntau tau nthuav tawm nyob rau hauv prostate cancer cell nto. N-terminus yog conjugated nrog HYNIC bifunctional chelator los ntawm kev hloov pauv tau yooj yim, uas tuaj yeem tsim cov chelate ruaj khov nrog 99mTc ntawm chav tsev kub nyob rau hauv qis acidic tej yam kev mob, nrog high labeling yield thiab zoo nyob rau hauv vivo stability. Cov ntawv sau npe molecule tshwj xeeb khaws cia hauv PSMA-cov ntaub so ntswg mob qog noj ntshav prostate zoo thiab metastases, ua tiav siab -kev sib piv SPECT imaging rau qog staging, lymph node thiab pob txha metastasis kev soj ntsuam, thiab kev saib xyuas zoo. Cov molecule no ua haujlwm ua cov cuab yeej tseem ceeb peptide rau prostate cancer radionuclide imaging research, PSMA targeted drug development, and radionuclide probe structure-activity analysis. | Kev tshawb fawb txog kev mob qog nqaij hlav prostate, Nuclear tshuaj SPECT imaging, PSMA lub hom phiaj kev tshawb fawb, qog nqaij hlav metastasis, Radionuclide sojntsuam kev loj hlob, Urology oncology tshawb fawb | Prostate-Specific Membrane Antigen (PSMA); HYNIC-99mTc chelation site; Tumor tsom mus rau enrichment thiab imaging pathway |
Cim npe nrov: cas 2213408-17-2 hynic-psma, Tuam Tshoj cas 2213408-17-2 hynic-psma manufacturers, lwm tus neeg, Hoobkas
